Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 18/20 | 0.78 |
| ▸ | CA1 | P00915 | 17/20 | 0.78 |
| ▸ | CA2 | P00918 | 17/20 | 0.78 |
| ▸ | CA12 | O43570 | 8/20 | 0.74 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.70 |
| ▸ | CA7 | P43166 | 2/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29699213 | 1.00 | CA9 (0.78) | CA9CA1CA2CA12CA14 | |
| SCHEMBL15828111 | 0.94 | CA9 (0.83) | CA9CA1CA2CA12CA14 | |
| SCHEMBL2234764 | 0.92 | CA9 (0.83) | CA9CA1CA2CA12CA14 | |
| SCHEMBL13097493 | 0.91 | CA9 (0.75) | CA9CA1CA2CA12CA14 | |
| SCHEMBL12060447 | 0.90 | CA9 (0.75) | CA9CA1CA2CA12CA14 | |
| SCHEMBL23169164 | 0.89 | CA9 (0.78) | CA9CA1CA2CA12CA14 | |
| SCHEMBL12231697 | 0.89 | CA9 (0.75) | CA9CA1CA2CA12CA14 | |
| SCHEMBL12231957 | 0.89 | CA9 (0.72) | CA9CA1CA2CA12CA14 | |
| SCHEMBL19954964 | 0.89 | CA9 (0.72) | CA9CA1CA2CA12CA14 | |
| SCHEMBL20622624 | 0.88 | CA9 (0.75) | CA9CA1CA2CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023132337-A1 | FLUORESCENT STAINING METHOD | 国立大学法人大阪大学 | 2023-07-13 | — | — | WO | disclosed |
| US-10718028-B2 | Fluorescent probes for abasic site detection | CASE WESTERN RESERVE UNIVERSITY (US) | 2020-07-21 | — | — | US | disclosed |
| EP-3313858-B1 | METHODS FOR THE SITE-SELECTIVE COUPLING OF A FIRST AGENT TO A SECOND AGENT | UNIV GENT (BE) | 2019-09-25 | — | — | EP | disclosed |
| US-20180127830-A1 | FLUORESCENT PROBES FOR ABASIC SITE DETECTION | CASE WESTERN RESERVE UNIVERSITY | 2018-05-10 | — | — | US | disclosed |
| US-20160282357-A1 | METHODS AND COMPOSITIONS RELATED TO NUCLEIC ACID BINDING ASSAYS | Nubad, LLC | 2016-09-29 | — | — | US | disclosed |
| US-9410186-B2 | Methods and compositions related to nucleic acid binding assays | NUBAD LLC (US) | 2016-08-09 | — | — | US | disclosed |
| US-9173946-B2 | Bifunctional hydroxy-bisphosphonic acid derivatives | ATLANTHERA (FR) | 2015-11-03 | — | — | US | disclosed |
| US-9173946-B2 | Bifunctional hydroxy-bisphosphonic acid derivatives | ATLANTHERA (FR) | 2015-11-03 | — | — | US | disclosed |
| US-9017943-B2 | Methods and compositions related to nucleic acid binding assays | NUBAD LLC (US) | 2015-04-28 | — | — | US | disclosed |
| US-20140330001-A1 | METHODS AND COMPOSITIONS RELATED TO NUCLEIC ACID BINDING ASSAYS | Nubad, LLC (US) | 2014-11-06 | — | — | US | disclosed |
| US-8716346-B2 | Alkylating agent combinations in the treatment of cancer | CASE WESTERN RESERVE UNIVERSITY (US) | 2014-05-06 | — | — | US | disclosed |
| US-20140086843-A1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | ATLANTHERA (FR) | 2014-03-27 | — | — | US | disclosed |
| US-20140086843-A1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | ATLANTHERA (FR) | 2014-03-27 | — | — | US | disclosed |
| US-20140024137-A1 | METHODS AND COMPOSITIONS RELATED TO NUCLEIC ACID BINDING ASSAYS | NUBAD LLC | 2014-01-23 | — | — | US | disclosed |
| US-8324282-B2 | Alkylating agent combinations in the treatment of cancer | CASE WESTERN RESERVE UNIVERSITY (US) | 2012-12-04 | — | — | US | disclosed |
| US-8324282-B2 | Alkylating agent combinations in the treatment of cancer | CASE WESTERN RESERVE UNIVERSITY (US) | 2012-12-04 | — | — | US | disclosed |
| WO-2012130911-A1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | ATLANTHERA (FR) | 2012-10-04 | — | — | WO | disclosed |
| US-20120065145-A1 | ALKYLATING AGENT COMBINATIONS IN THE TREATMENT OF CANCER | GERSON STANTON L (US) | 2012-03-15 | — | — | US | disclosed |
| US-7193034-B2 | Synthetic peptides, conjugation reagents and methods | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-03-20 | — | — | US | disclosed |
| US-7193034-B2 | Synthetic peptides, conjugation reagents and methods | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140086843-A1 | BIFUNCTIONAL HYDROXY-BISPHOSPHONIC ACID DERIVATIVES | BPGM, PHPT1, PTH1R | CA9 151/4885CA1 1156/4885CA2 208/4885 |
| US-10718028-B2 | Fluorescent probes for abasic site detection | OGG1, UNG, AP2B1 | CA9 3240/4885CA1 4084/4885CA2 1997/4885 |
| US-20180127830-A1 | FLUORESCENT PROBES FOR ABASIC SITE DETECTION | OGG1, UNG, AP2B1 | CA9 3240/4885CA1 4084/4885CA2 1997/4885 |
| US-20120065145-A1 | ALKYLATING AGENT COMBINATIONS IN THE TREATMENT OF CANCER | UNG, TOP2A, OGG1 | CA9 758/4885CA1 953/4885CA2 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.